skip to main content

ACS P2Y12 Selection — EECC MCQ

Instant feedback + full explanation. One question, done properly.

Moderate"Cardiology"ACS P2Y12 SelectionEECC

A 62-year-old with NSTEMI is loaded with aspirin. He has clopidogrel resistance previously documented. Which P2Y12 agent is preferred?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: BTicagrelor

Ticagrelor is preferred over clopidogrel for ACS and is effective in clopidogrel nonresponders. Prasugrel is contraindicated with prior stroke/TIA. Withholding P2Y12 (D) is inappropriate. Dipyridamole (E) is not used in ACS.

Reference: ACC/AHA/SCAI Guideline (2021): Coronary Artery Revascularization